Merck & Co. Inc. stock underperforms Tuesday when compared to competitors
Shares of Merck & Co. Inc. MRK slid 1.72% to $96.24 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.88% to 6,049.24 and ...
Merck price target lowered to $113 from $123 at Morgan Stanley
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $113 from $123 and keeps an Equal Weight rating on the ...
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
pharmaphorum23h
FDA clears Pfizer's Prevnar 20 for adults, as Merck rival nears decision
Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck & Co.
Reuters23h
Healthcare & Pharmaceuticals
Test tubes labelled "Bird Flu" and a piece of paper in the colours of the French national flag are seen in this picture illustration, January 14, 2023. REUTERS/Dado Ruvic/Illustration/File Photo ...